US2008097540A1PendingUtilityA1
Ecg input to implantable pulse generator using carotid sinus leads
Est. expirySep 26, 2021(expired)· nominal 20-yr term from priority
Inventors:Stephen L. BoleaRobert S. KievalBruce J. PerssonDavid J. SerdarPeter T. KeithEric IrwinMartin A. Rossing
A61B 5/02028A61N 1/3611A61N 1/36117A61N 1/36114A61N 1/0551A61N 1/36135A61N 1/36185A61N 1/05A61N 1/36053A61N 1/36125A61N 1/3702A61N 1/056
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A monitoring device is provided to monitor a patient. The monitoring device includes at least one lead having an electrode. The lead is positioned proximate a location within the patient's body, and the lead is adapted to sense cardiac electrical activity. The monitoring device also includes a control system coupled to the at least one lead to receive a signal representative of the cardiac electrical activity.
Claims
exact text as granted — not AI-modified1 . A monitoring device that monitors a patient, comprising:
at least one lead having an electrode, positioned proximate a location within a body of the patient and adapted to sense cardiac electrical activity; and a control system coupled to the at least one lead to receive a signal representative of the cardiac electrical activity.
2 . The monitoring device of claim 1 , wherein the at least one lead is positioned proximate a location selected from one of a carotid artery and a carotid sinus.
3 . The monitoring device of claim 1 , wherein the control system is adapted to generate an electrocardiogram based on the cardiac electrical activity sensed by the at least one lead.
4 . The monitoring device of claim 3 , wherein the control system is further adapted to store the electrocardiogram.
5 . A baroreflex activation system, comprising:
at least one lead having an electrode at a distal end, positioned proximate a location within the body of a patient and adapted to sense cardiac electrical activity; a control system coupled to the at least one lead and to receive a signal representative of the cardiac electrical activity, and to deliver a baroreflex therapy through the at least one lead.
6 . The baroreflex activation system of claim 5 , wherein the baroreflex therapy is delivered in response to the cardiac electrical activity sensed by the at least one lead.
7 . The baroreflex activation system of claim 5 , wherein the at least one lead is positioned proximate a baroreflex site selected from one of a carotid artery and a carotid sinus.
8 . The baroreflex activation system of claim 5 , wherein the control system is adapted to generate an electrocardiogram based on the sensed cardiac electrical activity.
9 . A method of monitoring cardiac activity and applying a baroreflex therapy for a patient, comprising:
implanting a baroreflex activation system within a body of the patient, the baroreflex activation device including a control system and at least one electrode, the at least one electrode adapted to deliver a signal and to sense cardiac electrical activity; positioning the at least one electrode at a location within the body of a patient; causing the baroreflex activation system to sense cardiac electrical activity via the at least one electrode; and causing the baroreflex activation system to deliver a baroreflex therapy.
10 . The method of claim 9 , wherein the baroreflex therapy delivered by the baroreflex activation system is modulated in response to the sensed cardiac electrical activity.
11 . The method of claim 10 , wherein the control system generates an electrocardiogram based on the sensed electrical cardiac activity by the at least one electrode.
12 . The method of claim 11 , wherein the at least one electrode is positioned proximate a baroreflex site selected from one of a carotid artery and a carotid sinus.
13 . A method of monitoring cardiac activity for a patient, comprising:
providing at least one lead having an electrode adapted to sense a cardiac parameter; providing a control system adapted to be coupled to the at least one lead to receive signals from the at least one lead representative of the cardiac parameter; and providing instructions to position the at least one lead proximate a first location within a body of the patient.
14 . The method of claim 13 , wherein the control system is adapted to generate an electrocardiogram based on the sensed cardiac electrical activity.
15 . The method of claim 14 , wherein providing instructions to position the at least one lead comprises providing instructions to position the at least one lead proximate a baroreflex site selected from one of a carotid artery and a carotid sinus.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.